Sarah Finnegan, MD
Neurology · Buffalo, NYNPI 1043288426
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $905 of the $1,255 with a category attached, or 72.1%. 9 manufacturers reported payments, led by Livanova USA, Inc. at 28.6% of the total. Reporting peaked in 2019 at $792 and has fallen 81.9% since, to $143 in 2025. That places this record below the midpoint for neurology clinicians in NY, where the typical reported total is $913.
Across 33 payments — averaging $38.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$359
- AbbVie$350
- UCB, Inc.$137
- Mallinckrodt Enterprises LLC$125
- Greenwich Biosciences, Inc.$110
- Neuropace, Inc.$99
- plus $75 from 3 others
What the payments were for
- Speaking & faculty fees$35028%
- Food & beverage$90572%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 20 | $359 |
| AbbVie | 1 | $350 |
| UCB, Inc. | 5 | $137 |
| Mallinckrodt Enterprises LLC | 1 | $125 |
| Greenwich Biosciences, Inc. | 1 | $110 |
| Neuropace, Inc. | 1 | $99 |
| Biogen | 2 | $42 |
| Biomarin Pharmaceutical Inc. | 1 | $20 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,255 in reported general payments places this provider in the 50th percentile of 1,623 neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 12 | $703 |
| Levetiracetam | 17 | $566 |
| Lamotrigine | 30 | $526 |
Paid to pharmacies, not to this prescriber.
Other neurology in Buffalo
- Gil WolfeBuffalo$617K
- David HojnackiBuffalo$480K
- Bianca Weinstock GuttmanBuffalo$288K
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.